Merck (MRK) Debt Ratio (2009 - 2026)
Merck (MRK) posted quarterly Debt Ratio of 0.38 for Q1 2026, up 26.11% year-over-year from 0.3 in Q1 2025, and up 5.88% quarter-over-quarter from 0.36 in Q4 2025.
Merck (MRK) Debt Ratio (2009 - 2026) Analysis & Trends
Merck (MRK) has reported Debt Ratio for 18 consecutive years, with 0.38 the latest figure, recorded in Q1 2026.
- In Q1 2026, Debt Ratio rose 26.11% year-over-year to 0.38; the TTM figure through Mar 2026 stood at 0.38 (up 26.11% YoY), while the FY2025 annual figure was 0.36, up 13.76% from the prior year.
- Debt Ratio rose to 0.38 in Q1 2026 per MRK's latest filing, from 0.36 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.38 in Q1 2026 and bottomed at 0.28 in Q4 2022.
- Historically, Debt Ratio has averaged 0.32 across 5 years, with a median of 0.32 in 2025.
- Annual changes were most pronounced in 2022 — Debt Ratio retreated 13.36% — and 2026, when it grew 26.11%.
- Merck's Debt Ratio stood at 0.28 in 2022, then climbed by 16.88% to 0.33 in 2023, then dropped by 3.56% to 0.32 in 2024, then rose by 13.76% to 0.36 in 2025, then increased by 5.88% to 0.38 in 2026.
- Business Quant data shows MRK's Debt Ratio at 0.38 in Q1 2026, 0.36 in Q4 2025, and 0.32 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.53 Bn | 631.77 Bn | 17.26 Bn | 0.24 |
| 2 | AbbVie | 469.73 Bn | 463.16 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 376.02 Bn | 368.88 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 303.27 Bn | 295.58 Bn | 11.24 Bn | 0.08 |
| 5 | Astrazeneca | 257.79 Bn | 252.89 Bn | 12.86 Bn | 0.25 |
| 6 | Amgen | 236.51 Bn | 222.53 Bn | 7.24 Bn | 0.66 |
| 7 | Gilead Sciences | 182.32 Bn | 179.14 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 159.52 Bn | 147.82 Bn | 10.94 Bn | 0.31 |
| 9 | Gsk | 106.18 Bn | 102.01 Bn | 8.24 Bn | -0.31 |
| 10 | Sanofi | 55.17 Bn | 47.79 Bn | 10.79 Bn | 0.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.42 |
| Mar 31, 2026 | 0.38 |
| Dec 31, 2025 | 0.36 |
| Sep 30, 2025 | 0.32 |
| Jun 30, 2025 | 0.30 |
| Mar 31, 2025 | 0.30 |
| Dec 31, 2024 | 0.32 |
| Sep 30, 2024 | 0.32 |
| Jun 30, 2024 | 0.34 |
| Mar 31, 2024 | 0.32 |
| Dec 31, 2023 | 0.33 |
| Sep 30, 2023 | 0.33 |
| Jun 30, 2023 | 0.35 |
| Mar 31, 2023 | 0.29 |
| Dec 31, 2022 | 0.28 |
| Sep 30, 2022 | 0.28 |
| Jun 30, 2022 | 0.30 |
| Mar 31, 2022 | 0.30 |
| Dec 31, 2021 | 0.31 |
| Sep 30, 2021 | 0.28 |